Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients

Annals of Oncology : Official Journal of the European Society for Medical Oncology
N KlugerD Bessis

Abstract

To analyze the clinical and histological features of permanent alopecia following a sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel regimen for adjuvant breast cancer treatment. Women treated for breast cancer by a sequential adjuvant FEC and docetaxel regimen who developed permanent alopecia diagnosed between 2007 and 2011 were identified from the Department of Dermatology (Saint-Eloi Hospital, Montpellier, France) and the Department of Medical Oncology (CRLC Val d'Aurelle, Montpellier, France). Data were collected regarding demographics, type of cancer, delay of onset after chemotherapy, Dermatology Life Quality Index (DLQI), clinical description of the lesions, scalp biopsies, laboratory explorations investigating steroid hormonal, iron, zinc and thyroid status, therapy and outcome. Twenty white Caucasian females were included. Hair loss presented with a moderate or intense androgenetic-like pattern of scalp alopecia. Biopsy specimen examinations were normal or displayed the androgenetic-like pattern. Laboratory explorations ruled out iron or zinc deficiency and thyroid disorders and confirmed hormonal menopause without hyperandrogenism. The overall mean DLQI score reflected the distressing psychologi...Continue Reading

References

May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
May 17, 2000·The Australasian Journal of Dermatology·D TranC W Chow
Aug 10, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·D WilliamsonA Y Finlay
Jan 5, 2002·Climacteric : the Journal of the International Menopause Society·M R SoulesN Woods
May 13, 2005·The British Journal of Dermatology·A TostiC Misciali
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henri RochéBernard Asselain
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Feb 19, 2009·The British Journal of Dermatology·C PrevezasP Reygagne
Apr 4, 2009·Seminars in Cutaneous Medicine and Surgery·Francisco M Camacho-Martínez
May 18, 2010·Journal of the American Academy of Dermatology·Ben TallonLynne J Goldberg
Feb 15, 2011·Journal of the American Academy of Dermatology·Ioulios PalamarasAntonella Tosti
Mar 25, 2011·The American Journal of Dermatopathology·Mariya MitevaAntonella Tosti
May 24, 2011·Journal of the American Academy of Dermatology·Erika Elise ReidHeather Wickless

❮ Previous
Next ❯

Citations

Apr 11, 2014·International Journal of Endocrinology and Metabolism·Ingrid Herskovitz, Antonella Tosti
Jan 1, 2013·Actas dermo-sifiliográficas·M T Fernández-Figueras, L Puig
Mar 20, 2013·Journal of Cutaneous Pathology·Margareth Pierre-LouisMaria K Hordinsky
Dec 21, 2013·Journal of the American Academy of Dermatology·Mira ChoiOhsang Kwon
Mar 20, 2015·Clinical and Experimental Dermatology·C ChampagneP Farrant
Feb 11, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C J G van den HurkF Boyle
Apr 12, 2018·JAMA Dermatology·Azael Freites-MartinezMario E Lacouture
Nov 24, 2018·Breast Cancer Research and Treatment·Raquel N RoznerMario E Lacouture
Sep 13, 2019·EMBO Molecular Medicine·Talveen S PurbaRalf Paus
Nov 21, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jenna R StoehrJennifer N Choi
Mar 23, 2017·Breast Cancer Research and Treatment·Gun Min KimJoohyuk Sohn
Aug 9, 2018·American Journal of Clinical Dermatology·Poonkiat Suchonwanit, Amy J McMichael
Aug 7, 2020·JAMA Dermatology·Gregory S PhillipsMario E Lacouture
Jan 4, 2019·American Journal of Clinical Dermatology·Jenna R StoehrStefan Vanderweil
Sep 19, 2020·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Takaaki FujiiKen Shirabe
Nov 18, 2016·The Medical Journal of Australia·Nicholas ZdenkowskiFrances M Boyle
Jul 25, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Danbee KangJuhee Cho
Jan 17, 2020·Plastic and Reconstructive Surgery. Global Open·Irena Sakura RiniAlberta Jesslyn Gunardi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Beatrice VergierJean-Philippe Merlio
The American Journal of Surgical Pathology
Pedram PouryazdanparastPedram Gerami
© 2021 Meta ULC. All rights reserved